X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-05 | DGX | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $174.13 | -5,370 | 72,495 | -7% | -$935,078 | ||||||
2025-03-04 | DGX | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $175.79 | -716 | 77,865 | -1% | -$125,866 | ||||||
2025-03-04 | DGX | Prevoznik Michael E | SVP, GC | S - Sale | $175.79 | -592 | 48,400 | -1% | -$104,068 | ||||||
2025-02-27 | DGX | Prevoznik Michael E | SVP, GC | S - Sale | $172.61 | -528 | 44,672 | -1% | -$91,138 | ||||||
2025-02-27 | DGX | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $172.61 | -824 | 73,606 | -1% | -$142,231 | ||||||
2025-02-20 | DGX | Prevoznik Michael E | SVP, GC | S - Sale | $170.99 | -604 | 45,486 | -1% | -$103,278 | ||||||
2025-02-19 | DGX | Plewman Patrick | SVP for Diagnostic Services | S - Sale | $169.71 | -320 | 18,082 | -2% | -$54,307 | ||||||
| M | 2025-02-19 | DGX | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $170.51 | -1,434 | 74,885 | -2% | -$244,515 | |||||
2025-02-05 | DGX | Gregg Vicky B | Dir | S - Sale | $164.57 | -1,250 | 16,867 | -7% | -$205,710 | ||||||
2025-02-05 | DGX | Delaney Mark E | SVP, Chief Commercial Officer | S - Sale | $164.30 | -403 | 4,624 | -8% | -$66,214 | ||||||
| D | 2024-11-29 | DGX | Prevoznik Michael E | SVP, GC | S - Sale+OE | $163.07 | -35,146 | 44,096 | -44% | -$5,731,302 | |||||
| D | 2024-11-27 | DGX | Doherty Catherine T. | EVP, Regional Businesses | S - Sale+OE | $162.99 | -33,103 | 72,804 | -31% | -$5,395,484 | |||||
| D | 2024-11-06 | DGX | Deppe Michael J | SVP, Corp. Controller, CAO | S - Sale+OE | $154.05 | -18,755 | 35,632 | -34% | -$2,889,123 | |||||
2024-10-28 | DGX | Kuppusamy Karthik | SVP, Clinical Solutions | S - Sale | $156.92 | -1,775 | 11,656 | -13% | -$278,525 | ||||||
| D | 2024-08-29 | DGX | Prevoznik Michael E | SVP, GC | S - Sale+OE | $154.97 | -32,551 | 44,070 | -42% | -$5,044,516 | |||||
2024-08-28 | DGX | Kuppusamy Karthik | SVP, Clinical Solutions | S - Sale | $153.26 | -1,990 | 13,373 | -13% | -$304,990 | ||||||
2024-07-24 | DGX | Delaney Mark E | SVP, Chief Commercial Officer | S - Sale | $143.08 | -420 | 5,019 | -8% | -$60,094 | ||||||
2024-04-29 | DGX | Kuppusamy Karthik | SVP, Clinical Solutions | S - Sale | $140.00 | -1,760 | 15,344 | -10% | -$246,400 | ||||||
| M | 2024-02-28 | DGX | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $126.45 | -6,744 | 72,761 | -8% | -$852,769 | |||||
2024-02-29 | DGX | Prevoznik Michael E | SVP, GC | S - Sale | $125.88 | -5,611 | 44,019 | -11% | -$706,313 | ||||||
2024-02-22 | DGX | Prevoznik Michael E | SVP, GC | S - Sale | $126.14 | -661 | 45,747 | -1% | -$83,379 | ||||||
2024-02-23 | DGX | Gregg Vicky B | Dir | S - Sale | $126.64 | -2,500 | 16,329 | -13% | -$316,597 | ||||||
2024-02-22 | DGX | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $126.14 | -821 | 75,149 | -1% | -$103,561 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |